Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05674240 · ClinicalTrials.gov registry record

Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain

A clinical trial of Chronic Pain and Neuropathic Pain, sponsored by Wake Forest University Health Sciences.

Active
Registry status
30
Enrollment target
1
Study location

NCT05674240 is a study of Chronic Pain and Neuropathic Pain that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05674240, a study of Chronic Pain and Neuropathic Pain, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.

ACTIVE NOT RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medication management only groups.

Interventions

  • DEVICE Intrathecal Targeted Drug Delivery
  • COMBINATION_PRODUCT Conservative medical management

Study Locations (1)

Wisconsin

  • Advocate Aurora Health - Oshkosh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-12-06
Est. Completion 2026-03-20

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05674240

The ClinicalTrials.gov registry entry for NCT05674240 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (96% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Intrathecal Targeted Drug Delivery is the first listed.

NCT05674240 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05674240 about?

NCT05674240 is a clinical study titled "Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain". This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medicati...

What is the current status of trial NCT05674240?

This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2022-12-06. Estimated completion is 2026-03-20.

What conditions does trial NCT05674240 study?

This clinical trial studies the following conditions: Chronic Pain, Neuropathic Pain, Cancer Pain, Cancer Associated Pain.

What interventions are being tested in trial NCT05674240?

The interventions under investigation include: Intrathecal Targeted Drug Delivery (DEVICE), Conservative medical management (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT05674240?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05674240 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.